Vaccine Contract Manufacturing Company

Partnering and Licensing

Resilience has several Vaccine Programs available for partnering and/or licensing.  These include Ross River (Phase III), Chikungunya, Pandemic and Seasonal Flu vaccines,  Yellow Fever (MVA), Typhoid, West Nile and Norovirus.  Please contact us for further information.

Resilience’s Vero Cell Platform – Veroplex® (DMF 10336, Master and Working Cell Banks)

Vero Cells

Optimized for production of vaccines, fully characterized, and successful track record:

  • Vero cell vaccines are licensed in the EU as well as in the US, Australia, New Zealand, and Brazil

  • Adapted to serum-free media

  • Suitable for production of all types of viral vaccines:

    • inactivated whole virus
    • live-attenuated
    • split/subunit

Learn more about how our proprietary Veroplex® technology can help you. Download a brochure below. Just enter your name and email address below and we’ll email you a download link:

References:
Barrett et al, Expert Rev. Vaccines 8(5), 607-618 (2009).
Barrett et al, Expert Rev. Vaccines 16(9), 883-894 (2017).

See the references

Resilience’s Delivery Platform for Vaccines and Biological Therapeutics – GelSite® (DMF 18741)
Suitable for multiple modes and routes of administration:

  • Unique in-situ gelation function and CGMP manufacturing process

Three delivery platform technologies based on GelSite polymer have been developed:

  • GelVac powder for nasal delivery of vaccines and protein/peptide therapeutics

  • Injectable formulation for protein/peptide therapeutics

  • Depot adjuvant for immunoenhancing and antigen sparing

Learn more about GelSite.® Download a brochure below. Just enter your name and email address below and we’ll email you a download link: